Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study von Mayer, Erica L, Dueck, Amylou C, Martin, Miguel, Rubovszky, Gabor, Burstein, Harold J, Bellet-Ezquerra, Meritxell, Miller, Kathy D, Zdenkowski, Nicholas, Winer, Eric P, Pfeiler, Georg, Goetz, Matthew, Ruiz-Borrego, Manuel, Anderson, Daniel, Nowecki, Zbigniew, Loibl, Sibylle, Moulder, Stacy, Ring, Alistair, Fitzal, Florian, Traina, Tiffany, Chan, Arlene, Rugo, Hope S, Lemieux, Julie, Henao, Fernando, Lyss, Alan, Antolin Novoa, Silvia, Wolff, Antonio C, Vetter, Marcus, Egle, Daniel, Morris, Patrick G, Mamounas, Eleftherios P, Gil-Gil, Miguel J, Prat, Aleix, Fohler, Hannes, Metzger Filho, Otto, Schwarz, Magdalena, DuFrane, Carter, Fumagalli, Debora, Theall, Kathy Puyana, Lu, Dongrui Ray, Bartlett, Cynthia Huang, Koehler, Maria, Fesl, Christian, DeMichele, Angela, Gnant, Michael

Volltext

AFT-16: Phase II trial of neoadjuvant and adjuvant atezolizumab and chemoradiation (CRT) for stage III non-small cell lung cancer (NSCLC) von Ross, Helen J., Kozono, David E., Urbanic, James John, Williams, Terence Marques, DuFrane, Carter, Bara, Ilze, Schulze, Katja, Brockman, Jane Michelle, Wang, Xiaofei F., Gao, Junheng, Vokes, Everett E., Stinchcombe, Tom

Volltext

AFT-16: Phase II trial of atezolizumab before and after definitive chemoradiation (CRT) for unresectable stage III non-small cell lung cancer (NSCLC) von Ross, Helen J., Kozono, David E., Urbanic, James John, Williams, Terence Marques, Dufrane, Carter, Bara, Ilze, Gandhi, Mayank, Schulze, Katja, Brockman, JaneMichelle Michelle, Wang, Xiaofei F., Gao, Junheng, Vokes, Everett E., Stinchcombe, Tom

Volltext

ALEXANDRA/IMpassion030: A phase 3 study of standard adjuvant chemotherapy with or without atezolizumab in patients with early-stage triple-negative breast cancer von Saji, Shigehira, McArthur, Heather L., Ignatiadis, Michail, Bailey, Andrew, El-Abed, Sarra, Brandao, Mariana, Metzger, Otto, Lai, Catherine, Guillaume, Sebastien, Fumagalli, Debora, Agbor-tarh, Dominique, Seiller, Aicha, Altarcheh Xifro, Rosa, Honvault, Vanessa, Viale, Giuseppe, DuFrane, Carter, Barata, Teresa, Winer, Eric P., Gelber, Richard D., Piccart-Gebhart, Martine J.

Volltext

Phase II trial of atezolizumab before and after definitive chemoradiation for unresectable stage III NSCLC von Ross, Helen J., Kozono, David E., Urbanic, James John, Williams, Terence Marques, Dufrane, Carter, Bara, Ilze, Gandhi, Mayank, Schulze, Katja, Brockman, Jane Michelle, Wang, Xiaofei F., Vokes, Everett E., Stinchcombe, Tom

Volltext

ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early-stage triple-negative breast cancer von McArthur, Heather L., Ignatiadis, Michail, Guillaume, Sebastian, Bailey, Andrew, Martinez, Jorge Luis, Brandao, Mariana, Metzger, Otto, Lai, Catherine, Fumagalli, Debora, Daly, Fergus, Bouhlel, Aicha, Karusinova, Valeria, Freeman, Christie, Viale, Giuseppe, Honvault, Vanessa, Dufrane, Carter, Nguyen Duc, Anh, Piccart, Martine J., Winer, Eric S., Gelber, Richard D.

Volltext